EW

Edwards Lifesciences (EW)

About Edwards Lifesciences (EW)

Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. It operates through the following geographical segments: United States, Europe, Japan, and Rest of World. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA.

Details

Daily high
$82.28
Daily low
$80.14
Price at open
--
52 Week High
$87.89
52 Week Low
$72.30
Market cap
46.9B
Dividend yield
0.00%
Volume
141
Avg. volume
5.4M
P/E ratio
44.21

Edwards Lifesciences News

Details

Daily high
$82.28
Daily low
$80.14
Price at open
--
52 Week High
$87.89
52 Week Low
$72.30
Market cap
46.9B
Dividend yield
0.00%
Volume
141
Avg. volume
5.4M
P/E ratio
44.21